ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Feb 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
January 2026
Latest News
Mirion announces appointments
Mirion Technologies has announced three senior leadership appointments designed to support its global nuclear and medical businesses while advancing a company-wide digital and AI strategy. The leadership changes come as Mirion seeks to advance innovation and maintain strong performance in nuclear energy, radiation safety, and medical applications.
D. Lynn Shaeffer, F. Owen Hoffman
Nuclear Technology | Volume 45 | Number 1 | August 1979 | Pages 99-106
Technical Paper | Radioactive Waste | doi.org/10.13182/NT79-A32288
Articles are hosted by Taylor and Francis Online.
An analysis was made of the uncertainty in the prediction of dose to an individual’s thyroid due to the transport of radioactive molecular iodine, 131I2, from air through the pasture-cow-milk pathway. This analysis was facilitated by the adoption of a model consisting of a multiplication of several factors represented by lognormal distributions of values. Results indicate there is a 64, 50, or 23% chance of the annual dose to an individual’s thyroid not exceeding the mean, median, or most probable doses, respectively. However, these results are tentative as a result of the limited amount of data available for annual average dose assessments. The suggestion is made that consideration be given to adopting a probabilistic approach to determining an acceptable probability of an individual receiving a dose that exceeds a limiting value.